IL15 and neoplasm: Mechanistic investigation showed that IL-15 expression induced greater in vivo expansion of CAR-T cells and tumor T-cell infiltration, which is likely related to the enhanced antitumor efficacy of H9 CAR-IL15 T cells, as previously described for IL-15-modified mouse and human engineered T cells (14–16, 18, 19, 27).